2015 Abwarie Target Plan

Addis Ababa Regional
Health Bureau
S.No Activity Total Estimated
RMH_FP_CAR Contraceptive acceptance rate
Total new and repeat acceptors,
FP_CAR_Age disaggregated by age 1670 2004
FP_CAR_Age_New Contraceptive new acceptors by age 1019 1222.8
FP_CAR_Age_New. 1 10 - 14 years 0
FP_CAR_Age_New. 2 15 - 19 years 73 87.6
FP_CAR_Age_New. 5 30 - 49 years 290 348
FP_CAR_Age_Rep Contraceptive repeat acceptors by age 651 781.2
FP_CAR_Age_Rep. 1 10 - 14 years 0
FP_CAR_Age_Rep. 2 15 - 19 years 18 21.6
Total new and repeat acceptors,
FP_CAR_MTd disaggregated by method 1670 2004
FP_CAR_Mtd_New Contraceptive new acceptors, by method 1019 1222.8

FP_CAR_Mtd_New. 1 Oral contraceptives 99 118.8
FP_CAR_Mtd_New. 2 Injectables 436 523.2
FP_CAR_Mtd_New. 3 Implants 391 469.2
FP_CAR_Mtd_New. 4 IUD 41 49.2
FP_CAR_Mtd_New. 5 Vasectomy 0
FP_CAR_Mtd_New. 6 Tubal ligation 0
FP_CAR_Mtd_New. 7 Others 52 62.4
Contraceptive repeat acceptors, by
FP_CAR_Mtd_Rep method 651 781.2
FP_CAR_Mtd_Rep. 1 Oral contraceptives 55 66
FP_CAR_Mtd_Rep. 2 Injectables 583 699.6
FP_CAR_Mtd_Rep. 3 Implants 11 13.2
FP_CAR_Mtd_Rep. 4 IUD 1 1.2
FP_CAR_Mtd_Rep. 5 Vasectomy 0
FP_CAR_Mtd_Rep. 6 Tubal ligation 0
FP_CAR_Mtd_Rep. 7 Others 1 1.2
Immediate Postpartum Contraceptive
RMH_FP_IPPF Acceptance (IPPFP) 0
Total Immediate Postpartum

Contraceptive acceptors disaggregated by
FP_IPPF_Age age 8 9.6
FP_IPPF_Age. 1 10 - 14 years 0
FP_IPPF_Age. 2 15 - 19 years 0
FP_IPPF_Age. 3 20 - 24 years 5 6
FP_IPPF_Age. 4 25 - 29 years 2 2.4
FP_IPPF_Age. 5 30 - 49 years 1 1.2
Total Immediate Postpartum

Contraceptive acceptors disaggregated by
FP_IPPF_Mtd method 8 9.6
FP_IPPF_Mtd. 1 Pills (POP) 0
FP_IPPF_Mtd. 2 Implants 2 2.4
FP_IPPF_Mtd. 3 IUD 6 7.2
FP_IPPF_Mtd. 4 Tubal ligation 0
FP_IPPF_Mtd. 5 Others 0
RMH_FP_LAFPPR Premature Removal of LAFP methods 0
Total Long acting family planning (LAFP)

FP_TtLAFPR. removal in the reporting period 99 118.8
Total number of premature removal of

Long acting family planning (LAFP) within 6
FP_LAFPPR_Pre month insertion 4 4.8
FP_LAFPPR_Pre. 1 Implants 4 4.8
FP_LAFPPR_Pre. 2 IUD 0
FP_LAFPPR_Pre. 3 Others 0
RMH_ANC_1stV Antenatal Care coverage - First visit 0
Number of pregnant women who received

ANC_1stV_GA.1 ANC first visit by gestational week 486 583.2
ANC_1stV_GA.1. 1 < 16 weeks gestation 312 374.4
ANC_1stV_GA.1. 2 >= 16 weeks gestation 174 208.8
Number of pregnant women that received

Antenatal Care (ANC) at least once by
ANC_1stV_MA maternal age 486 583.2
ANC_1stV_MA. 1 10 - 14 years 0
ANC_1stV_MA. 2 15 - 19 years 16 19.2
ANC_1stV_MA. 3 >= 20 years 470 564
Total number of pregnant women that

received Antenatal Care (ANC): at least
ANC_4thV_MA four visits by maternal age 284 340.8
ANC_4thV_MA. 1 10 - 14 years 0
ANC_4thV_MA. 2 15 - 19 years 6 7.2
ANC_4thV_MA. 3 >= 20 years 278 333.6
Pregnant women attending antenatal care
RMH_ANC_Syph tested for syphilis 0
Total number of pregnant women tested
ANC_Syph for syphilis 486 583.2
ANC_Syph. 1 Reactive 0
ANC_Syph. 2 Non-Reactive 486 583.2
Total number of Reactive pregnant women
ANC_Syph.RX. treated for syphilis 0
Pregnant women attending antenatal care
RMH_ANC_Hepa tested for hepatitis (B&C) 0
Total number of pregnant women tested
ANC_Hepa for Hepatitis (B & C) 486 583.2
ANC_Hepa. 1 Reactive 0
ANC_Hepa. 2 Non-Reactive 486 583.2
Total number of pregnant women treated
ANC_Hepa_RX. for Hepatitis (B&C) 0
RMH_L&D_SBA Births attended by skilled health personnel 0

Total number of births attended by skilled
L&D_SBA.1. health personnel 156 187.2
RMH_L&D_SBR Still birth rate 117.6 141.12
L&D_SBR.SB. Number of still births 2 2.4 0.012821
NCH_CHIM_EIND Early Institutional Neonatal Death Rate 0

L&D_SBR.LB. Number of Live births 154 184.8
B&D_Ntfc Birth and death notifications 0
B&D_Ntfc.1. Number of birth notifications given 161 193.2
B&D_Ntfc.2. Number of death notifications given 2 2.4
RMH_PNC_E1stV Early Postnatal Care Coverage 0
Number of Postnatal visits within 7 days of
PNC_E1stV.1 delivery 420 504
PNC_E1stV.1. 2 24Hrs (1day) 161 193.2
PNC_E1stV.1. 3 25 - 48 hrs (1 - 2 days) 0
PNC_E1stV.1. 4 49 - 72 hrs (2 - 3 days) 131 157.2
PNC_E1stV.1. 5 73 hrs - 7 days (4 - 7 days) 128 153.6
RMH_L&D_CS Caesarean section 0
Number of women having given birth by
L&D_CS. caesarean section 0
Number of women receiving

comprehensive abortion care services dis
RMH_CAC aggregated by maternal age 93 111.6
RMH_CAC_SAC Number of safe abortions performed 81 97.2
RMH_CAC_SAC. 1 10 - 14 years 0
RMH_CAC_SAC. 2 15 - 19 years 13 15.6
RMH_CAC_SAC. 3 20 - 24 years 36 43.2
RMH_CAC_SAC. 4 25 - 29 years 24 28.8
RMH_CAC_SAC. 5 >= 30 years 8 9.6
RMH_CAC_PAC Number of post abortion/emergency care 12 14.4

RMH_CAC_PAC. 1 10 - 14 years 0
RMH_CAC_PAC. 2 15 - 19 years 0
RMH_CAC_PAC. 3 20 - 24 years 1 1.2
RMH_CAC_PAC. 4 25 - 29 years 4 4.8
RMH_CAC_PAC. 5 >= 30 years 7 8.4
Number of women receiving

comprehensive abortion care
RMH_CAC disaggregated by trimester 93 111.6
RMH_CAC. 1 First trimester(<12 Weeks) 93 111.6
RMH_CAC. 2 Second trimester(>=12 Weeks) 0
RMH_IMD_IMMR Institutional maternal deaths 0
Number of maternal deaths in health
IMD_IMMR. facility 0
Total number of teenage girls tested
TngP_TPR positive for pregnancy 51 61.2
TngP_TPR. 1 10 - 14 years 0
TngP_TPR. 2 15 - 19 years 51 61.2
Total number of women tested positive
RMH_TtP. pregnancy 164 196.8
PMTCT (Prevention of HIV Mother to Child
RMH_PMTCT Transmission) 0
Number of pregnant women tested and

PMTCT_TST_1. know their HIV result during pregnancy 550 660
Number of pregnant women tested and

know their HIV result during labour &
PMTCT_TST_2. delivery 11 13.2
Number of women tested and know their

PMTCT_TST_3. HIV result during the postpartum period 5 6
Number of women with known HIV

positive status attending ANC, delivery and
postpartum for new pregnancy linked from
PMTCT_KNpos. Pre ART and ART 1 1.2
Number of new HIV positive women
PMTCT_NWpos. during ANC, L&D and Postpartum 5 6
The facility provides PMTCT and/or ART
service 10 12
Percentage of HIV-positive pregnant

women who received ART to reduce the
risk of Women-to child-transmission
RMH_PMTCT_ARV (MTCT) during pregnancy, L&D and PNC 0
Number of HIV positive women who
received ART to reduce the risk of mother
to child transmission during ANC for the
PMTCT_ARV_1. first time 4 4.8
Number of HIV positive Pregnant women

who received ART to reduce the risk of
mother to child transmission during L&D
PMTCT_ARV_2. for the first time 0
Number of HIV positive lactating women

who received ART to reduce the risk of
mother to child transmission during PNC
PMTCT_ARV_3. for the first time 1 1.2
Number of HIV-positive women who get

PMTCT_ARV_4. pregnant while on ART and linked to ANC 6 7.2
Total number of infants within 12 months

received virological test result 10 12
Number of HIV exposed infants who

received a virological HIV test 0-2 Months
PMTCT_IPCR.1 of birth 8 9.6
PMTCT_IPCR.1. 1 Positive 0
PMTCT_IPCR.1. 2 Negative 8 9.6

received a virological HIV test 2-12 Months
PMTCT_IPCR.1.2 of birth 2 2.4
PMTCT_IPCR.1.2. 1 Positive 0
PMTCT_IPCR.1.2. 2 Negative 2 2.4
Percentage of Infants born to HIV-infected

women started on co-trimoxazole
RMH_PMTCT_ICPT prophylaxis within two months of birth 0
Number of infants born to HIV positive

women started on co-trimoxazole
PMTCT_ICPT.1. prophylaxis within two months of birth 9 10.8
Percentage of Infants born to HIV-infected

women receiving antiretroviral (ARV)
prophylaxis for prevention of Women-to-
RMH_PMTCT_IARV child transmission (PMTCT) 0
PMTCT_IARV_1. received ARV prophylaxis For 6 weeks 1 1.2
PMTCT_IARV_2. received ARV prophylaxis For 12 weeks 5 6
Number of HIV positive women who gave
RMH_L&D_pos. birth at health institution 2 2.4
Percentage of partners of pregnant,

laboring and lactating women tested for
RMH_PMTCT_PRN_TST HIV 0
Number of partners of pregnant, laboring

and lactating women tested for HIV and
PMTCT_PRN_TST. know their results 97 116.4
Number of partners of pregnant, laboring

and lactating women whose test result is
PMTCT_PRN_Pos. HIV positive 2 2.4
Number of HIV exposed infants receiving

HIV confirmatory (antibody test) by 18
RMH_PMTCT_IABT months 5 6
RMH_PMTCT_IABT. 1 Positive 0
RMH_PMTCT_IABT. 2 Negative 5 6
NCH_EPI Expanded Program of Immunization (EPI) 0

Number of children under one year of age
EPI_BCG. who have received BCG vaccine 324 388.8

who have received first dose of
EPI_Penta1. pentavalent vaccine 475 570

who have received third dose of
EPI_Penta3. pentavalent vaccine 453 543.6

who have received first dose of
EPI_PCV1. pneumococcal vaccine 475 570

who have received third dose of
EPI_PCV3. pneumococcal vaccine 453 543.6

who have received first dose of polio
EPI_PV1. vaccine 467 560.4

who have received third dose of Polio
EPI_PV3. vaccine 453 543.6

who have received one dose of inactivated
EPI_IPV. polio vaccine 417 500.4
who have received first dose of Rotavirus
EPI_RT1. vaccine 475 570

who have received 2nd dose of Rotavirus
EPI_RT2. vaccine 441 529.2

who have received first dose of measles
EPI_MCV1. vaccine 414 496.8
Number of children received all vaccine
EPI_FI. doses before 1st birthday 443 531.6
Number of children under two years of age

who have received second dose of measles
EPI_MCV2. vaccine 494 592.8
Number of Infants whose mothers had

EPI_PAB. protective doses of TT against NNT (PAB) 422 506.4
EPI_HPV HPV Vaccination 0
Number of girls 14 year of age who have

received first dose of human papilloma
EPI_HPV1. virus vaccine 141 169.2
Number of girls 14 years of age who have

received second dose of human
papillomavirus vaccine in 6 month interval
EPI_HPV2. from the first dose 239 286.8
RMH_MV_TT TT Vaccination 0
Number of women who have received TT1
MV_TT1. vaccination 457 548.4
MV_TT2. vaccination 387 464.4
MV.TT3. vaccination 0
MV.TT4. vaccination 0
MV.TT5.. vaccination 0
HCSM_EPI_VWR Vaccine Wastage Rate 0
VWR_BCG BCG Vaccine wastage rate 275.4 330.48
VWR_BCG_giv. BCG doses given (all ages) 324 388.8
VWR_BCG_opn. BCG doses opened 460 552
VWR_BCG_dam. BCG doses damaged 0
VWR_BCG_dis. BCG doses expired 0
VWR_Penta Penta Vaccine wastage rate 33.9 40.68
Pentavalent (DPT-HepB-Hib) doses given
VWR_Penta_giv. (all ages) 1369 1642.8
VWR_Penta_opn. Pentavalent (DPT-HepB-Hib) doses opened 1429 1714.8
Pentavalent (DPT-HepB-Hib) doses
VWR_Penta_dam. damaged 0
VWR_Penta_dis. Pentavalent (DPT-HepB-Hib) doses expired 0

VWR_PCV PCV Vaccine wastage rate 8.47 10.164
Pneumococcal conjugated vaccine doses
VWR_PCV_giv. given (all ages) 1261 1513.2
VWR_PCV_opn. opened 1273 1527.6
VWR_PCV_dam. damaged 0
VWR_PCV_dis. expired 0
Rota Vaccine wastage rate 20.8 24.96
VWR_RT_giv. Rota doses give (all ages) 916 1099.2
VWR_RT_opn. Rota doses opened 946 1135.2
VWR_RT_dam. Rota doses damaged 0
VWR_RT_dis. Rota doses expired 0
VWR_PV Polio Vaccine wastage rate 18.63 22.356
VWR_PV_giv. Polio doses given (all ages) 1498 1797.6
VWR_PV_opn. Polio doses opened 1530 1836
VWR_PV_dam. Polio doses damaged 0
VWR_PV_dis. Polio doses expired 0
VWR_MCV Measles Vaccine wastage rate 49.2 59.04
VWR_MCV_giv. Measles doses given (all ages) 908 1089.6
VWR_MCV_opn. Measles doses opened 956 1147.2
VWR_MCV_dam. Measles doses damaged 0
VWR_MCV_dis. Measles doses expired 0
TT Vaccine wastage rate 44.2 53.04
VWR_TT_opn. TT doses given 849 1018.8
VWR_TT_giv. TT doses opened 886 1063.2
VWR_TT_dam. TT doses damaged 0
VWR_TT_dis. TT doses expired 0
VWR_IPV IPV Vaccine wastage rate 60 72
VWR_IPV_giv. IPV doses given 475 570
VWR_IPV_opn. IPV doses opened 506 607.2
VWR_IPV_dam. IPV doses damaged 0
VWR_IPV_dis. IPV doses expired 0
VWR_HPV HPV Vaccine wastage rate 0 0
VWR_HPV_giv. HPV doses given 380 456
VWR_HPV_opn. HPV doses opened 380 456
VWR_HPV_dam. HPV doses damaged 0
VWR_HPV_dis. HPV doses expired 0
NCH_CHIM_EIND 0
Number of neonatal deaths in the first 7
NCH_CHIM_EIND days of life(Institutional) 0
NCH_CHIM_EIND. 1 First 24 hrs of life 0
NCH_CHIM_EIND. 2 1-7 days of life 0
Under-five children with pneumonia
NCH_CHIM_PnRX received antibiotic treatment 0
Number of under 5 children treated for
CHIM_PnRX. pneumonia 67 80.4
Number of sick young infants 0-2 months
NCH_CHIM_VSD treated for sepsis 0
CHIM_VSD_sep. treated for sepsis 2 2.4

CHIM_VSD_lbi. treated for local bacterial infection (LBI) 12 14.4
Proportion of children who are treated for
NCH_CHIM_DhRX Diarrhea 0
Number of children treated for diarrhea
CHIM_DhRX_orszinc. with ORS and zinc 156 187.2
Number of children treated for diarrhea
CHIM_DhRX_orsonly. with ORS only 142 170.4
Proportion of low birth weight and/or

premature newborns for whom KMC was
NCH_CHIM_KMC initiated after delivery 0
Total number of newborns weighing

<2000gm and/or premature newborns for
CHIM_KMC.1. which KMC initiated 0
Total number of newborns weighing
CHIM_E4KMC. <2000gm and/or premature 0
Asphyxiated neonates who were

resuscitated (with bag & mask) and
NCH_CHIM_AsfxRS survived 0
Total number of neonates resuscitated
CHIM_AsfxRS. and survived 0
CHIM_AsfxR. Total number of neonates resuscitated 0

NCH_NTR Maternal and Child Nutrition 0
Percentage of low birth weight (LBW)
NCH_NTR_LBW newborns 0 0
Number of live-born babies with birth
NTR_LBW_1. weight less than 2500 gm 0
NTR_LBW_2. Total number of live births weighed 154 184.8
Promotion of GMP participation among
NCH_NTR_GMP children under 2 yr 0
Number of children less than 2 years
NTR_GMP weighted during GMP session 1613 1935.6
NTR_GMP. 1 0 - 5 months 203 243.6
NTR_GMP. 2 6 - 23 months 1410 1692
Number of weights recorded with

moderate malnutrition by age (Z score b/n
NTR_GMP_MM -2 & -3) 182 218.4
NTR_GMP_MM. 1 0 - 5 months 34 40.8
NTR_GMP_MM. 2 6 - 23 months 148 177.6
Number of weights recorded with severe

GMP_SM malnutrition by age ( Z score below -3) 10 12
GMP_SM. 1 0 - 5 months 0
GMP_SM. 2 6 - 23 months 10 12
Children aged <5 yr screened for acute
NTR_S4AM malnutrition 0
Total number of children <5yrs screened
NTR_S4AM for acute malnutrition 3942 4730.4
NTR_S4AM. 1 0 - 5 months 149 178.8
NTR_S4AM. 2 6 - 59 months 3793 4551.6
Number of children <5 year screened and

S4AM_MAM have moderate acute malnutrition 19 22.8
S4AM_MAM. 1 0 - 5 months 0
S4AM_MAM. 2 6 - 59 months 19 22.8
Number of children <5 year screened and
S4AM_SAM have severe acute malnutrition 15 18
S4AM_SAM. 1 0 - 5 months 0
S4AM_SAM. 2 6 - 59 months 15 18
Treatment outcome for management of

severe acute malnutrition in children
NCH_NTR_SAM_RXO under 5 yr (OTP and SC) 0
Treatment outcome for management of
NTR_SAM_RXO_1 SAM in children under 5 years 13 15.6
NTR_SAM_RXO_1. 1 Recovered 9 10.8
NTR_SAM_RXO_1. 2 Died 0
NTR_SAM_RXO_1. 3 Transferred out 2 2.4
NTR_SAM_RXO_1. 4 Defaulted 2 2.4
NTR_SAM_RXO_1. 5 Non-respondent 0
NTR_SAM_RXO_1. 6 Medical transfer 0
NTR_SAM_RXO_1. 7 Unknown status 0
Number of children who exit from severe

acute malnutrition treatment during the
NTR_SAM_Exit. reporting period 5 6
Number of children with SAM admitted to
NTR_SAM_Adt. TFP(OTP &SC) during the reporting period 19 22.8
Total number of children aged 6-59

months who received Vitamin A
NTR_VAS_1 supplementation - by age 3411 4093.2
NTR_VAS_1. 1 6 - 11 months 810 972
NTR_VAS_1. 2 12 - 59 months 2601 3121.2
Total number of children aged 6-59

months who received Vitamin A
NTR_VAS_2 supplementation - by dose 3411 4093.2
NTR_VAS_2. 1 First dose 1382 1658.4
NTR_VAS_2. 2 Second dose 2029 2434.8
Total number of children aged 24 - 59
NTR_DWR months dewormed 2452 2942.4
NTR_DWR. 1 First dose 857 1028.4
NTR_DWR. 2 Second dose 1595 1914
Total number of PLW screened for acute
PLW_S4AM malnutrition 720 864
PLW_S4AM. 1 MUAC < 23 cm 1 1.2
PLW_S4AM. 2 MUAC >= 23 cm 719 862.8
Total number of Pregnant women received
ANC_IFA IFA at least 90 plus 539 646.8
ANC_IFA. 1 10 - 14 years 0
ANC_IFA. 2 15 - 19 years 15 18
ANC_IFA. 3 >= 20 years 524 628.8
RMH_ANC_DWR. Number of pregnant women de-wormed 311 373.2

CDC_HIV HIV/AIDS 0
HIV_VCT Clients receiving HIV test results at VCT 433 519.6

HIV_VCT. 1 < 1 year, Male 0
HIV_VCT. 2 < 1 year, Female 0
HIV_VCT. 3 1 - 4 years, Male 1 1.2
HIV_VCT. 4 1 - 4 years, Female 0
HIV_VCT. 6 5 - 9 years, Female 0
HIV_VCT. 7 10 - 14 years, Male 130 156
HIV_VCT. 8 10 - 14 years, Female 7 8.4
HIV_VCT. 12 20 - 24 years, Female 60 72
HIV_VCT. 15 >= 50 years, Male 4 4.8
HIV_VCT. 16 >= 50 years, Female 2 2.4
HIV_VCT_Pos.1 Clients testing positive for HIV at VCT 2 2.4
HIV_VCT_Pos.1. 1 < 1 year, Male 0
HIV_VCT_Pos.1. 2 < 1 year, Female 0
HIV_VCT_Pos.1. 3 1 - 4 years, Male 0
HIV_VCT_Pos.1. 4 1 - 4 years, Female 0
HIV_VCT_Pos.1. 13 25 - 49 years, Male 1 1.2
HIV_VCT_Pos.1. 14 25 - 49 years, Female 1 1.2
HIV_VCT_Pos.1. 15 >= 50 years, Male 0
HIV_VCT_Pos.1. 16 >= 50 years, Female 0
HIV_PITC Clients receiving HIV test results at PITC 1079 1294.8

HIV_PITC. 1 < 1 year, Male 0
HIV_PITC. 2 < 1 year, Female 3 3.6
HIV_PITC. 3 1 - 4 years, Male 6 7.2
HIV_PITC. 4 1 - 4 years, Female 5 6
HIV_PITC. 5 5 - 9 years, Male 0
HIV_PITC. 6 5 - 9 years, Female 1 1.2
HIV_PITC. 10 15 - 19 years, Female 45 54
HIV_PITC. 15 >= 50 years, Male 17 20.4
HIV_PITC. 16 >= 50 years, Female 21 25.2
HIV_PITC_Pos Clients testing positive for HIV at PITC 16 19.2
HIV_PITC_Pos. 1 < 1 year, Male 0
HIV_PITC_Pos. 2 < 1 year, Female 0
HIV_PITC_Pos. 3 1 - 4 years, Male 0
HIV_PITC_Pos. 4 1 - 4 years, Female 0
HIV_PITC_Pos. 10 15 - 19 years, Female 1 1.2
HIV_PITC_Pos. 13 25 - 49 years, Male 2 2.4
HIV_PITC_Pos. 15 >= 50 years, Male 0
HIV_PITC_Pos. 16 >= 50 years, Female 2 2.4
HIV_HCT_PG HCT by population group 0
Number of individuals who have been

tested and Counseled for HIV and received
HIV_HCT.1 their results by Population group 0
Female commercial Sex workers - received
HIV_HCT_PG.1. result 2 2.4
Female commercial Sex workers - tested
HIV_HCT_PG.1.1. positive 0
HIV_HCT_PG.2. Long distance drivers - received result 5 6
HIV_HCT_PG.2.1. Long distance drivers - tested positive 0
HIV_HCT_PG.3. Mobile/Daily Laborers - received result 3 3.6
HIV_HCT_PG.3.1. Mobile/Daily Laborers - tested positive 0

HIV_HCT_PG.4. OVC - received result 0
HIV_HCT_PG.4.1. OVC - tested positive 0
HIV_HCT_PG.5. Children of PLHIV - received result 0
HIV_HCT_PG.5.1. Children of PLHIV - tested positive 0
HIV_HCT_PG.6. Prisoners - received result 0
HIV_HCT_PG.6.1. Prisoners - tested positive 0
HIV_HCT_PG.7. Partners of PLHIV - received result 0
HIV_HCT_PG.7.1. Partners of PLHIV - tested positive 0
HIV_HCT_PG.8. Other MARPs - received result 21 25.2
HIV_HCT_PG.8.1. Other MARPs - tested positive 1 1.2
HIV_HCT_PG.9. HCT in general population - received result 1412 1694.4
HIV_HCT_PG.9.1. HCT in general population - tested positive 17 20.4

STI Cases Tested for HIV in the Reporting
CDC_STI_PITC Period 0
STI_PITC Number of STI cases tested for HIV 147 176.4
STI_PITC. 1 Positive, Male 0
STI_PITC. 2 Positive, Female 0
STI_PITC. 3 Negative, Male 65 78
STI_PITC. 4 Negative, Female 82 98.4
CDC_STI Total number of STI cases by sex 157 188.4
CDC_STI. 1 Male 69 82.8
CDC_STI. 2 Female 88 105.6
CDC_STI_Sy Total number of STI cases by syndrome 117 140.4

CDC_STI_Sy. 1 Urethral discharge 46 55.2
CDC_STI_Sy. 2 Persistent urethral discharge 2 2.4
CDC_STI_Sy. 3 Scrotal swelling 1 1.2
CDC_STI_Sy. 4 Vaginal discharge 59 70.8
CDC_STI_Sy. 5 PID (pelvic inflammatory disease) 4 4.8
Non vesicular genital ulcer disease
CDC_STI_Sy. 6 (NVGUD) 4 4.8
CDC_STI_Sy. 7 Vesicular genital ulcer disease (VGUD) 1 1.2
CDC_STI_Sy. 8 Inguinal bubo 0
CDC_STI_Sy. 9 Neonatal conjunctivitis 0
CDC_STI_Sy. 10 Neonatal herpes 0
Number of adults and children who are
currently on ART 942 1130.4
Number of adults who are currently on
ART by regimen type 942 1130.4
HIV_RXC.1.1.1 Adult aged 15-19 yrs currently on ART 30 36
Adult 15-19 years currently on ART on first
HIV_RXC.1.1.1.1 line regimen 30 36
HIV_RXC.1.1.1.1. 1 1c = AZT-3TC-NVP, Male 0
HIV_RXC.1.1.1.1. 2 1c = AZT-3TC-NVP, Female 0
HIV_RXC.1.1.1.1. 3 1d = AZT-3TC-EFV, Male 0
HIV_RXC.1.1.1.1. 4 1d = AZT-3TC-EFV, Female 0
HIV_RXC.1.1.1.1. 5 1e = TDF-3TC-EFV, Male 0
HIV_RXC.1.1.1.1. 6 1e = TDF-3TC-EFV, Female 0
HIV_RXC.1.1.1.1. 7 1f= TDF + 3TC+ NVP, Male 0
HIV_RXC.1.1.1.1. 8 1f= TDF + 3TC+ NVP, Female 0
HIV_RXC.1.1.1.1. 9 1g= ABC + 3TC + EFV, Male 0
HIV_RXC.1.1.1.1. 10 1g= ABC + 3TC + EFV, Female 0
HIV_RXC.1.1.1.1. 11 1h= ABC + 3TC NVP, Male 0
HIV_RXC.1.1.1.1. 12 1h= ABC + 3TC NVP, Female 0
HIV_RXC.1.1.1.1. 13 Others, Male 1 1.2
HIV_RXC.1.1.1.1. 14 Others, Female 1 1.2
HIV_RXC.1.1.1.1. 15 1j=TDF + 3TC + DTG, Male 9 10.8
HIV_RXC.1.1.1.1. 16 1j=TDF + 3TC + DTG, Female 19 22.8
HIV_RXC.1.1.1.1. 17 1k= AZT +3TC +DTG, Male 0
HIV_RXC.1.1.1.1. 18 1k= AZT +3TC +DTG, Female 0
Adult 15-19 years currently on ART on
HIV_RXC.1.1.1.1.2 second line regimen 0
HIV_RXC.1.1.1.1.2. 1 2e= AZT+3TC+LPV/r, Male 0
HIV_RXC.1.1.1.1.2. 2 2e= AZT+3TC+LPV/r, Female 0
HIV_RXC.1.1.1.1.2. 3 2f=AZT+3TC+ATV/r, Male 0
HIV_RXC.1.1.1.1.2. 4 2f=AZT+3TC+ATV/r, Female 0
HIV_RXC.1.1.1.1.2. 5 2g= TDF-3TC-LPV/r, Male 0
HIV_RXC.1.1.1.1.2. 6 2g= TDF-3TC-LPV/r, Female 0
HIV_RXC.1.1.1.1.2. 7 2h =TDF-3TC-ATV/r, Male 0
HIV_RXC.1.1.1.1.2. 8 2h =TDF-3TC-ATV/r, Female 0
HIV_RXC.1.1.1.1.2. 9 2i = ABC + 3TC + LPV/r, Male 0
HIV_RXC.1.1.1.1.2. 10 2i = ABC + 3TC + LPV/r, Female 0
HIV_RXC.1.1.1.1.2. 11 Others, Male 0
HIV_RXC.1.1.1.1.2. 12 Others, Female 0
HIV_RXC.1.1.1.1.3 third line regimen 0
HIV_RXC.1.1.1.1.3. 1 3a=DRV/r+DTG+AZT/3TC, Male 0
HIV_RXC.1.1.1.1.3. 2 3a=DRV/r+DTG+AZT/3TC, Female 0
HIV_RXC.1.1.1.1.3. 3 3b=DRV/r+DTG+TDF/3TC, Male 0
HIV_RXC.1.1.1.1.3. 4 3b=DRV/r+DTG+TDF/3TC, Female 0
HIV_RXC.1.1.1.1.3. 5 Others, Male 0
HIV_RXC.1.1.1.1.3. 6 Others, Female 0
HIV_RXC.1.1.1.1.3. 7 3d= DRV/r + ABC + EFV + 3TC, Male 0
HIV_RXC.1.1.1.1.3. 8 3d= DRV/r + ABC + EFV + 3TC, Female 0
HIV_RXC.1.1.2 Adult aged 20-24 yrs currently on ART 38 45.6
HIV_RXC.1.1.2.1 line regimen 38 45.6
HIV_RXC.1.1.2.1. 13 Others, Male 0
HIV_RXC.1.1.2.1. 14 Others, Female 0
HIV_RXC.1.1.2.1. 15 1j=TDF + 3TC + DTG, Male 10 12
HIV_RXC.1.1.2.2 second line regimen 0
HIV_RXC.1.1.2.2. 1 2e= AZT+3TC+LPV/r, Male 0
HIV_RXC.1.1.2.2. 2 2e= AZT+3TC+LPV/r, Female 0
HIV_RXC.1.1.2.2. 3 2f=AZT+3TC+ATV/r, Male 0
HIV_RXC.1.1.2.2. 4 2f=AZT+3TC+ATV/r, Female 0
HIV_RXC.1.1.2.2. 5 2g= TDF-3TC-LPV/r, Male 0
HIV_RXC.1.1.2.2. 6 2g= TDF-3TC-LPV/r, Female 0
HIV_RXC.1.1.2.2. 7 2h =TDF-3TC-ATV/r, Male 0
HIV_RXC.1.1.2.2. 8 2h =TDF-3TC-ATV/r, Female 0
HIV_RXC.1.1.2.2. 9 2i = ABC + 3TC + LPV/r, Male 0
HIV_RXC.1.1.2.2. 10 2i = ABC + 3TC + LPV/r, Female 0
HIV_RXC.1.1.2.3 third line regimen 0
HIV_RXC.1.1.2.3. 1 3a=DRV/r+DTG+AZT/3TC, Male 0
HIV_RXC.1.1.2.3. 2 3a=DRV/r+DTG+AZT/3TC, Female 0
HIV_RXC.1.1.2.3. 3 3b=DRV/r+DTG+TDF/3TC, Male 0
HIV_RXC.1.1.2.3. 4 3b=DRV/r+DTG+TDF/3TC, Female 0
HIV_RXC.1.1.2.3. 7 3d= DRV/r + ABC + EFV + 3TC, Male 0
HIV_RXC.1.1.2.3. 8 3d= DRV/r + ABC + EFV + 3TC, Female 0
HIV_RXC.1.1.3 Adult aged 25-49 yrs currently on ART 769 922.8
HIV_RXC.1.1.3.1 line regimen 769 922.8
HIV_RXC.1.1.3.1. 15 1j=TDF + 3TC + DTG, Male 208 249.6
HIV_RXC.1.1.4 Adult aged 50+ yrs currently on ART 105 126
Adult >=50 years currently on ART on first
HIV_RXC.1.1.4.1 line regimen 105 126
HIV_RXC.1.1.4.1. 15 1j=TDF + 3TC + DTG, Male 30 36
HIV_RXC.1.1.4.1. 16 1j=TDF + 3TC + DTG, Female 75 90
Adult >=50 years currently on ART on
Adult >=50 years currently on ART on third
HIV_RXC.1.1.4.3 line regimen 0
Number of children who are currently on
ART by regimen type 0 0
HIV_RXC.1.2.1 Children aged <1 yr currently on ART 0 0
Infants <1 years currently on ART on First
HIV_RXC.1.2.1.1 Line Regimen 0
HIV_RXC.1.2.1.1. 3 4f=AZT + 3TC + LPV/r, Male 0
HIV_RXC.1.2.1.1. 4 4f=AZT + 3TC + LPV/r, Female 0
HIV_RXC.1.2.1.1. 5 4g=ABC + 3TC + LPV/r, Male 0
HIV_RXC.1.2.1.1. 6 4g=ABC + 3TC + LPV/r, Female 0
Infants <1 years currently on ART on
HIV_RXC.1.2.1.2. 1 5e=ABC + 3TC + LPV/r, Male 0
HIV_RXC.1.2.1.2. 2 5e=ABC + 3TC + LPV/r, Female 0
HIV_RXC.1.2.1.2. 5 5j=ABC+ 3TC+ LPV/r, Male 0
HIV_RXC.1.2.1.2. 6 5j=ABC+ 3TC+ LPV/r, Female 0
HIV_RXC.1.2.1.2. 9 5k= RAL + AZT + 3TC, Male 0
HIV_RXC.1.2.1.2. 10 5k= RAL + AZT + 3TC, Female 0
HIV_RXC.1.2.1.2. 11 5l= RAL + ABC + 3TC, Male 0
HIV_RXC.1.2.1.2. 12 5l= RAL + ABC + 3TC, Female 0
HIV_RXC.1.2.2 Children aged 1-4 yrs currently on ART 0 0
Children 1 - 4 years currently on ART on
HIV_RXC.1.2.2.1 first line regimen 0
HIV_RXC.1.2.2.1. 11 4j= ABC +3TC + DTG, Male 0
HIV_RXC.1.2.2.1. 12 4j= ABC +3TC + DTG, Female 0
HIV_RXC.1.2.2.1. 13 4k= AZT + 3TC + DTG, Male 0
HIV_RXC.1.2.2.1. 14 4k= AZT + 3TC + DTG, Female 0
HIV_RXC.1.2.2.1. 15 4l= ABC + 3TC + EFV, Male 0
HIV_RXC.1.2.2.1. 16 4l= ABC + 3TC + EFV, Female 0
HIV_RXC.1.2.2.2. 5 5h=ABC + 3TC + EFV, Male 0
HIV_RXC.1.2.2.2. 6 5h=ABC + 3TC + EFV, Female 0
HIV_RXC.1.2.2.2. 7 5j=ABC+ 3TC+ LPV/r, Male 0
HIV_RXC.1.2.2.2. 8 5j=ABC+ 3TC+ LPV/r, Female 0
HIV_RXC.1.2.2.2. 15 5m = ABC + 3TC + DTG, Male 0
HIV_RXC.1.2.2.2. 16 5m = ABC + 3TC + DTG, Female 0
HIV_RXC.1.2.2.2. 17 5n= AZT + 3TC + DTG, Male 0
HIV_RXC.1.2.2.2. 18 5n= AZT + 3TC + DTG, Female 0
HIV_RXC.1.2.2.3. 1 6a=DRV/r+RAL+AZT+3TC, Male 0
HIV_RXC.1.2.2.3. 2 6a=DRV/r+RAL+AZT+3TC, Female 0
HIV_RXC.1.2.2.3. 3 6b=DRV/r+RAL+TDF+3TC, Male 0
HIV_RXC.1.2.2.3. 4 6b=DRV/r+RAL+TDF+3TC, Female 0
HIV_RXC.1.2.2.3. 7 6c=DRV/r+DTG+AZT+3TC, Male 0
HIV_RXC.1.2.2.3. 8 6c=DRV/r+DTG+AZT+3TC, Female 0
HIV_RXC.1.2.2.3. 9 6f= DRV/r + DTG + ABC + 3TC, Male 0
HIV_RXC.1.2.2.3. 10 6f= DRV/r + DTG + ABC + 3TC, Female 0
HIV_RXC.1.2.3.1. 5 4e= TDF-3TC-EFV, Male 0
HIV_RXC.1.2.3.1. 6 4e= TDF-3TC-EFV, Female 0
HIV_RXC.1.2.3.2. 5 5g= TDF + 3TC + EFV, Male 0
HIV_RXC.1.2.3.2. 6 5g= TDF + 3TC + EFV, Female 0
HIV_RXC.1.2.3.2. 9 5i=TDF + 3TC+ LPV/r, Male 0
HIV_RXC.1.2.3.2. 10 5i=TDF + 3TC+ LPV/r, Female 0

HIV_RXC.1.2.4.1. 5 4e= TDF-3TC-EFV, Male 0
HIV_RXC.1.2.4.1. 6 4e= TDF-3TC-EFV, Female 0
HIV_RXC.1.2.4.1. 13 4i= TDF + 3TC + DTG, Male 0
HIV_RXC.1.2.4.1. 14 4i= TDF + 3TC + DTG, Female 0
HIV_RXC.1.2.4.2. 5 5g= TDF + 3TC + EFV, Male 0
HIV_RXC.1.2.4.2. 6 5g= TDF + 3TC + EFV, Female 0
HIV_RXC.1.2.4.2. 9 5i=TDF + 3TC+ LPV/r, Male 0
HIV_RXC.1.2.4.2. 10 5i=TDF + 3TC+ LPV/r, Female 0
HIV_RXC.1.2.4.3. 7 6d=DRV/r+DTG+TDF+3TC, Male 0
HIV_RXC.1.2.4.3. 8 6d=DRV/r+DTG+TDF+3TC, Female 0
Number of PLHIV who are documented as
HIV_RXC_LTF. lost/lost to follow up 2 2.4
Number of adults and children with HIV
CDC_HIV_RXN infection newly started on ART 34 40.8
CDC_HIV_RXN. 1 < 1 year, Male 0
CDC_HIV_RXN. 3 < 1 year, Female - non-pregnant 0
CDC_HIV_RXN. 4 1 - 4 years, Male 0
CDC_HIV_RXN. 6 1 - 4 years, Female - non-pregnant 0
CDC_HIV_RXN. 14 15 - 19 years, Female - pregnant 0
CDC_HIV_RXN. 15 15 - 19 years, Female - non-pregnant 1 1.2
CDC_HIV_RXN. 17 20 - 24 years, Female - pregnant 3 3.6
CDC_HIV_RXN. 18 20 - 24 years, Female - non-pregnant 1 1.2
CDC_HIV_RXN. 19 25 - 49 years, Male 15 18
CDC_HIV_RXN. 20 25 - 49 years, Female - pregnant 2 2.4
CDC_HIV_RXN. 21 25 - 49 years, Female - non-pregnant 10 12
CDC_HIV_RXN. 22 >= 50 years, Male 1 1.2
CDC_HIV_RXN. 24 >= 50 years, Female - non-pregnant 1 1.2
Number of adults and children who are

still on treatment at 12 months after
HIV_RtR_1 initiating ART 13 15.6
HIV_RtR_1. 1 < 1 year, Male 0
HIV_RtR_1. 3 < 1 year, Female - non-pregnant 0
HIV_RtR_1. 4 1 - 4 years, Male 0
HIV_RtR_1. 6 1 - 4 years, Female - non-pregnant 0
HIV_RtR_1. 14 15 - 19 years, Female - pregnant 0
HIV_RtR_1. 15 15 - 19 years, Female - non-pregnant 1 1.2
HIV_RtR_1. 17 20 - 24 years, Female - pregnant 0
HIV_RtR_1. 19 25 - 49 years, Male 2 2.4
HIV_RtR_1. 20 25 - 49 years, Female - pregnant 1 1.2
HIV_RtR_1. 21 25 - 49 years, Female - non-pregnant 8 9.6
HIV_RtR_1. 22 >= 50 years, Male 0
HIV_RtR_1. 24 >= 50 years, Female - non-pregnant 1 1.2
Number of persons on ART in the original

cohort including those transferred in,
minus those transferred out (net current
HIV_NCC cohort) 31 37.2
HIV_NCC. 1 < 1 year, Male 0
HIV_NCC. 3 < 1 year, Female - non-pregnant 0
HIV_NCC. 4 1 - 4 years, Male 0
HIV_NCC. 6 1 - 4 years, Female - non-pregnant 0
HIV_NCC. 14 15 - 19 years, Female - pregnant 0
HIV_NCC. 15 15 - 19 years, Female - non-pregnant 1 1.2
HIV_NCC. 17 20 - 24 years, Female - pregnant 1 1.2
HIV_NCC. 19 25 - 49 years, Male 3 3.6
HIV_NCC. 20 25 - 49 years, Female - pregnant 1 1.2
HIV_NCC. 21 25 - 49 years, Female - non-pregnant 24 28.8
HIV_NCC. 22 >= 50 years, Male 0
HIV_NCC. 24 >= 50 years, Female - non-pregnant 1 1.2
Percentage of ART clients with

undetectable viral load at 6 month after
initiation of ART 500 600
Number of adult and pediatric patients

with an undetectable viral load <1,000
HIV_UVLC_6M copies/ml at 6 months 15 18
HIV_UVLC_6M. 1 < 1 year, Male 0
HIV_UVLC_6M. 3 < 1 year, Female - non-pregnant 0
HIV_UVLC_6M. 4 1 - 4 years, Male 0
HIV_UVLC_6M. 6 1 - 4 years, Female - non-pregnant 0
HIV_UVLC_6M. 13 15 - 19 years, Male 1 1.2
HIV_UVLC_6M. 14 15 - 19 years, Female - pregnant 0
HIV_UVLC_6M. 15 15 - 19 years, Female - non-pregnant 1 1.2
HIV_UVLC_6M. 17 20 - 24 years, Female - pregnant 0
HIV_UVLC_6M. 20 25 - 49 years, Female - pregnant 2 2.4
HIV_UVLC_6M. 21 25 - 49 years, Female - non-pregnant 8 9.6
HIV_UVLC_6M. 22 >= 50 years, Male 1 1.2
HIV_UVLC_6M. 24 >= 50 years, Female - non-pregnant 0
Number of adults and children who

initiated ART in the 6 months prior to the
beginning of the reporting period with a
HIV_VLC_6M viral load count at 6 month visit 11 13.2
HIV_VLC_6M. 1 < 1 year, Male 0
HIV_VLC_6M. 3 < 1 year, Female - non-pregnant 0
HIV_VLC_6M. 4 1 - 4 years, Male 0
HIV_VLC_6M. 6 1 - 4 years, Female - non-pregnant 0
HIV_VLC_6M. 13 15 - 19 years, Male 1 1.2
HIV_VLC_6M. 14 15 - 19 years, Female - pregnant 0
HIV_VLC_6M. 15 15 - 19 years, Female - non-pregnant 1 1.2
HIV_VLC_6M. 17 20 - 24 years, Female - pregnant 0
HIV_VLC_6M. 20 25 - 49 years, Female - pregnant 2 2.4
HIV_VLC_6M. 21 25 - 49 years, Female - non-pregnant 4 4.8
HIV_VLC_6M. 22 >= 50 years, Male 1 1.2
HIV_VLC_6M. 24 >= 50 years, Female - non-pregnant 0
Number of adult and pediatric patients

with an undetectable viral load <1,000
HIV_SVLC copies/ml in the reporting period 16 19.2
HIV_SVLC. 1 < 1 year, Male 0
HIV_SVLC. 3 < 1 year, Female - non-pregnant 0
HIV_SVLC. 4 1 - 4 years, Male 0
HIV_SVLC. 6 1 - 4 years, Female - non-pregnant 0
HIV_SVLC. 14 15 - 19 years, Female - pregnant 0
HIV_SVLC. 17 20 - 24 years, Female - pregnant 0
HIV_SVLC. 19 25 - 49 years, Male 4 4.8
HIV_SVLC. 20 25 - 49 years, Female - pregnant 1 1.2
HIV_SVLC. 21 25 - 49 years, Female - non-pregnant 10 12
HIV_SVLC. 22 >= 50 years, Male 0
HIV_SVLC. 24 >= 50 years, Female - non-pregnant 1 1.2
Number of adult and pediatric ART

patients at 12 month (yearly) viral load
HIV_VLC test in the reporting period 36 43.2
HIV_VLC. 1 < 1 year, Male 0
HIV_VLC. 3 < 1 year, Female - non-pregnant 0
HIV_VLC. 4 1 - 4 years, Male 0
HIV_VLC. 6 1 - 4 years, Female - non-pregnant 0
HIV_VLC. 13 15 - 19 years, Male 2 2.4
HIV_VLC. 14 15 - 19 years, Female - pregnant 0
HIV_VLC. 17 20 - 24 years, Female - pregnant 0
HIV_VLC. 18 20 - 24 years, Female - non-pregnant 1 1.2
HIV_VLC. 19 25 - 49 years, Male 10 12
HIV_VLC. 20 25 - 49 years, Female - pregnant 3 3.6
HIV_VLC. 21 25 - 49 years, Female - non-pregnant 19 22.8
HIV_VLC. 22 >= 50 years, Male 0
HIV_VLC. 24 >= 50 years, Female - non-pregnant 1 1.2
Number of PLHIV who were
HIV_NTR_S4M assessed/screened for malnutrition 236 283.2
HIV_NTR_S4M. 1 < 1 year, Male 0
HIV_NTR_S4M. 3 < 1 year, Female - non-pregnant 0
HIV_NTR_S4M. 4 1 - 4 years, Male 0
HIV_NTR_S4M. 6 1 - 4 years, Female - non-pregnant 0
HIV_NTR_S4M. 13 15 - 19 years, Male 3 3.6
HIV_NTR_S4M. 14 15 - 19 years, Female - pregnant 0
HIV_NTR_S4M. 15 15 - 19 years, Female - non-pregnant 3 3.6
HIV_NTR_S4M. 17 20 - 24 years, Female - pregnant 1 1.2
HIV_NTR_S4M. 18 20 - 24 years, Female - non-pregnant 7 8.4
HIV_NTR_S4M. 19 25 - 49 years, Male 71 85.2
HIV_NTR_S4M. 20 25 - 49 years, Female - pregnant 8 9.6
HIV_NTR_S4M. 21 25 - 49 years, Female - non-pregnant 120 144
HIV_NTR_S4M. 22 >= 50 years, Male 6 7.2
HIV_NTR_S4M. 24 >= 50 years, Female - non-pregnant 17 20.4
Number of PLHIV that were nutritionally

assessed and found to be clinically
undernourished - by age sex and
HIV_NTR_S4MU.1 pregnancy 24 28.8
HIV_NTR_S4MU.1. 1 < 1 year, Male 0
HIV_NTR_S4MU.1. 3 < 1 year, Female - non-pregnant 0
HIV_NTR_S4MU.1. 4 1 - 4 years, Male 0
HIV_NTR_S4MU.1. 6 1 - 4 years, Female - non-pregnant 0
HIV_NTR_S4MU.1. 14 15 - 19 years, Female - pregnant 0
HIV_NTR_S4MU.1. 17 20 - 24 years, Female - pregnant 0
HIV_NTR_S4MU.1. 19 25 - 49 years, Male 4 4.8
HIV_NTR_S4MU.1. 20 25 - 49 years, Female - pregnant 1 1.2
HIV_NTR_S4MU.1. 21 25 - 49 years, Female - non-pregnant 18 21.6
HIV_NTR_S4MU.1. 22 >= 50 years, Male 0
HIV_NTR_S4MU.1. 24 >= 50 years, Female - non-pregnant 1 1.2
Number of PLHIV that were nutritionally

assessed and found to be clinically
HIV_NTR_S4MU.2 undernourished - by nutritional status 8 9.6
HIV_NTR_S4MU.2. 1 MAM 8 9.6
HIV_NTR_S4MU.2. 2 SAM 0
Number of clinically undernourished PLHIV

who received therapeutic or
supplementary food by age sex and
HIV_NTR_S4MU_TF.1 pregnancy status 5 6
HIV_NTR_S4MU_TF.1. 1 < 1 year, Male 0
HIV_NTR_S4MU_TF.1. 3 < 1 year, Female - non-pregnant 0
HIV_NTR_S4MU_TF.1. 4 1 - 4 years, Male 0
HIV_NTR_S4MU_TF.1. 6 1 - 4 years, Female - non-pregnant 0
HIV_NTR_S4MU_TF.1. 14 15 - 19 years, Female - pregnant 0
HIV_NTR_S4MU_TF.1. 17 20 - 24 years, Female - pregnant 0

HIV_NTR_S4MU_TF.1. 19 25 - 49 years, Male 2 2.4
HIV_NTR_S4MU_TF.1. 20 25 - 49 years, Female - pregnant 1 1.2
HIV_NTR_S4MU_TF.1. 21 25 - 49 years, Female - non-pregnant 1 1.2
HIV_NTR_S4MU_TF.1. 22 >= 50 years, Male 0
HIV_NTR_S4MU_TF.1. 24 >= 50 years, Female - non-pregnant 1 1.2
Number of clinically undernourished PLHIV

who received therapeutic or
HIV_NTR_S4MU_TF.2 supplementary food - by nutritional status 2 2.4
HIV_NTR_S4MU_TF.2. 1 MAM 2 2.4
HIV_NTR_S4MU_TF.2. 2 SAM 0
Number of persons provided with post-

exposure prophylaxis (PEP) for risk of HIV
HIV_PEP.1 infection 1 1.2
HIV_PEP.1. 1 Non occupational risk 0
HIV_PEP.1. 2 Occupational risk 1 1.2
Number of persons exposed for HIV
HIV_PE4HIV infection eligible for PEP 1 1.2
HIV_PE4HIV. 1 Non occupational risk 0
HIV_PE4HIV. 2 Occupational risk 1 1.2
Number of PLHIV women aged 15-49

reporting the use of any method of
HIV_FP_Mtd modern family planning 4 4.8
HIV_FP_Mtd. 1 Long acting 1 1.2
HIV_FP_Mtd. 2 Short acting 3 3.6
Number of PLHIV women aged 15-49

reporting the use of any method of
HIV_FP_Age modern family planning by age 4 4.8
HIV_FP_Age. 1 10 - 14 years 0
HIV_FP_Age. 4 25 - 49 years 4 4.8
Number of clients enrolled in HIV care who

were screened for TB during the reporting
HIV_TBSC.1 period 191 229.2
HIV_TBSC.1. 1 < 1 year, Male 0
HIV_TBSC.1. 3 < 1 year, Female - non-pregnant 0
HIV_TBSC.1. 4 1 - 4 years, Male 0
HIV_TBSC.1. 6 1 - 4 years, Female - non-pregnant 0
HIV_TBSC.1. 13 15 - 19 years, Male 3 3.6
HIV_TBSC.1. 14 15 - 19 years, Female - pregnant 0
HIV_TBSC.1. 15 15 - 19 years, Female - non-pregnant 3 3.6
HIV_TBSC.1. 17 20 - 24 years, Female - pregnant 0
HIV_TBSC.1. 19 25 - 49 years, Male 56 67.2
HIV_TBSC.1. 20 25 - 49 years, Female - pregnant 5 6
HIV_TBSC.1. 22 >= 50 years, Male 6 7.2
HIV_TBSC.1. 24 >= 50 years, Female - non-pregnant 14 16.8
Total number of HIV positive clients

identified with active TB during reporting
HIV_TBPos.1 period 6 7.2
HIV_TBPos.1. 1 < 15 years, Male 0
HIV_TBPos.1. 2 < 15 years, Female 0
HIV_TBPos.1. 3 >= 15 years, Male 4 4.8
HIV_TBPos.1. 4 >= 15 years, Female 2 2.4
Total number of newly started ART clients

HIV_TBPos.2 with active TB in the reporting period 0
HIV_TBPos.2. 1 < 15 years, Male 0
HIV_TBPos.2. 2 < 15 years, Female 0
HIV_TBPos.2. 3 >= 15 years, Male 0
HIV_TBPos.2. 4 >= 15 years, Female 0
Total number of newly enrolled ART clients

HIV_IPTE1 initiated on LTBI Treatment - IPT 7 8.4
HIV_IPTE1. 1 < 15 years, Male 0
HIV_IPTE1. 2 < 15 years, Female 0
HIV_IPTE1. 3 >= 15 years, Male 4 4.8
HIV_IPTE1. 4 >= 15 years, Female 3 3.6
Total number of newly enrolled ART clients

HIV_IPTE2 initiated on LTBI Treatment - 3HP 0
HIV_IPTE2. 1 < 15 years, Male 0
HIV_IPTE2. 2 < 15 years, Female 0
HIV_IPTE2. 3 >= 15 years, Male 0
HIV_IPTE2. 4 >= 15 years, Female 0
Total number of PLHIV completed LTBI

treatment (receiving IPT/3HP) during the
HIV_IPT_CRX.1_Type reporting period 0
HIV_IPT_CRX.1_Type. 1 IPT 0
HIV_IPT_CRX.1_Type. 2 3HP 0
Total number of adult PLHIV newly

HIV_IPT_ASM.1.1 enrolled for ASM in the reporting period 18 21.6
HIV_IPT_ASM.1.1. 1 Male 8 9.6
HIV_IPT_ASM.1.1. 2 Female 10 12
Total number of adult PLHIV currently on
HIV_IPT_ASM.1.2 ASM in the reporting period 83 99.6
HIV_IPT_ASM.1.2. 1 Male 30 36
HIV_IPT_ASM.1.2. 2 Female 53 63.6
Total number of clients identified for pre-

Exposure prophylaxis in the reporting
HIV_IPT_PreE.1 period 0
HIV_IPT_PreE.1. 1 Sero discordant 0
HIV_IPT_PreE.1. 2 Female sex worker 0
Total number of clients newly enrolled on

Pre-Exposure prohylaxis (PrEP) in the
HIV_IPT_PreE.2 reporting period 3 3.6
HIV_IPT_PreE.2. 1 Sero discordant 3 3.6
Total number of clients completed Pre-

exposure prohylaxis (PrEP) in the reporting
HIV_IPT_PreE.3 period 0
HIV_IPT_PreE.3. 1 Sero discordant 0
CDC_Mal Malaria 0
Mal_Pos Malaria positivity rate 141.9 170.28
Number of slides or RDT positive for
Mal_Pos.1 malaria 8 9.6
Mal_Pos.1. 1 < 5 years, Male 0
Mal_Pos.1. 2 < 5 years, Female 0
Mal_Pos.1. 3 5 - 14 years, Male 0
Mal_Pos.1. 4 5 - 14 years, Female 0
Mal_Pos.1. 5 >= 15 years, Male 6 7.2
Mal_Pos.1. 6 >= 15 years, Female 2 2.4
Total number of slides or RDT performed
Mal_DX. for malaria diagnosis 71 85.2
Number of women aged 30 - 49 screened
CA_VIA.1 with VIA for cervical cancer 166 199.2
CA_VIA.1. 1 Normal cervix 148 177.6
CA_VIA.1. 2 Precancerous lesion 9 10.8
CA_VIA.1. 3 Cancerous lesion 9 10.8
Number of women aged 30-49 year with
CA_SCCAL_RX.1 cervical lesion received treatment 4 4.8
CA_SCCAL_RX.1. 1 Crayotherapy 4 4.8
CA_SCCAL_RX.1. 2 LEEP 0
NCDC_DM Diabetes mellitus 0
Total number of individuals screened for

NCDC_DM_Sc1 diabetes in the reporting period 384 460.8
NCDC_DM_Sc1. 1 40 - 49 years, Male 76 91.2
NCDC_DM_Sc1. 2 40 - 49 years, Female 83 99.6
NCDC_DM_Sc1. 3 50 - 59 years, Male 67 80.4
NCDC_DM_Sc1. 4 50 - 59 years, Female 50 60
NCDC_DM_Sc1. 5 60 - 69 years, Male 20 24
NCDC_DM_Sc1. 6 60 - 69 years, Female 40 48
NCDC_DM_Sc1. 7 >=70 years, Male 22 26.4
NCDC_DM_Sc1. 8 >=70 years, Female 26 31.2
Total number of individuals with raised

blood sugar among screened for diabetes
NCDC_DM2 in the reporting period 17 20.4
NCDC_DM2. 1 40 - 49 years, Male 2 2.4
NCDC_DM2. 2 40 - 49 years, Female 6 7.2
NCDC_DM2. 4 50 - 59 years, Female 5 6
NCDC_DM2. 6 60 - 69 years, Female 0
NCDC_DM2. 7 >=70 years, Male 2 2.4
NCDC_DM2. 8 >=70 years, Female 0
Total number of new diabetic patients
NCDC_DM_NW3 enrolled to care 27 32.4
NCDC_DM_NW3. 1 < 40 years, Male 3 3.6
NCDC_DM_NW3. 2 < 40 years, Female 4 4.8
NCDC_DM_NW3. 3 40 - 49 years, Male 2 2.4
NCDC_DM_NW3. 4 40 - 49 years, Female 6 7.2
NCDC_DM_NW3. 5 50 - 59 years, Male 2 2.4
NCDC_DM_NW3. 6 50 - 59 years, Female 5 6
NCDC_DM_NW3. 7 60 - 69 years, Male 0
NCDC_DM_NW3. 8 60 - 69 years, Female 3 3.6
NCDC_DM_NW3. 9 >=70 years, Male 1 1.2
NCDC_DM_NW3. 10 >=70 years, Female 1 1.2
Total number of diabetic patients put on

NCDC_DM_N_Rx3. drug treatment in the reporting period 28 33.6
Total number of diabetic patients
NCDC_DM_TP4 disaggregated by type 384 460.8
NCDC_DM_TP4. 1 Diabetes mellitus Type I 14 16.8
NCDC_DM_TP4. 2 Diabetes mellitus Type II 370 444
NCDC_DM_TP4. 3 Gestational Diabetes mellitus (GDM) 0
Total number of cohort diabetic patients

enrolled to care six month prior to the
NCDC_DM_Rx5. reporting month 111 133.2
Total number of diabetic patients enrolled

to care six month prior to the reporting
NCDC_DM_Rx6 month 407 488.4
NCDC_DM_Rx6. 1 Controlled 245 294
NCDC_DM_Rx6. 2 Not controlled 161 193.2
NCDC_DM_Rx6. 3 Lost to follow-up 1 1.2
NCDC_DM_Rx6. 4 Died 0
NCDC_DM_Rx6. 5 Transferred out 0
NCDC_HT Hypertension 0
Total number of individuals screened for

NCDC_HT_Sc1 hypertension in the reporting period 1818 2181.6
NCDC_HT_Sc1. 3 30 - 49 years, Male 279 334.8
NCDC_HT_Sc1. 4 30 - 49 years, Female 350 420
NCDC_HT_Sc1. 5 50 - 59 years, Male 286 343.2
NCDC_HT_Sc1. 6 50 - 59 years, Female 305 366
NCDC_HT_Sc1. 7 >=70 years, Male 318 381.6
NCDC_HT_Sc1. 8 >=70 years, Female 280 336
Total number of individuals with raised

blood pressure among screened for
NCDC_HT2 hypertension in the reporting period 38 45.6
NCDC_HT2. 3 30 - 49 years, Male 0
NCDC_HT2. 4 30 - 49 years, Female 7 8.4
NCDC_HT2. 5 50 - 59 years, Male 4 4.8
NCDC_HT2. 6 50 - 59 years, Female 14 16.8
NCDC_HT2. 7 >=70 years, Male 4 4.8
NCDC_HT2. 8 >=70 years, Female 9 10.8
Total number of new hypertensive
NCDC_HT_Nw3 patients enrolled to care 38 45.6
NCDC_HT_Nw3. 1 < 30 years, Male 0
NCDC_HT_Nw3. 2 < 30 years, Female 2 2.4
NCDC_HT_Nw3. 3 30 - 49 years, Male 1 1.2
NCDC_HT_Nw3. 4 30 - 49 years, Female 4 4.8
NCDC_HT_Nw3. 5 50 - 59 years, Male 5 6
NCDC_HT_Nw3. 6 50 - 59 years, Female 9 10.8
NCDC_HT_Nw3. 7 >=70 years, Male 8 9.6
NCDC_HT_Nw3. 8 >=70 years, Female 9 10.8
Total number of hypertensive patients put

NCDC_HT_Nw_Rx3. on drug treatment in the reporting period 35 42
Total number of hypertensive patients

NCDC_HT_Nw4 enrolled to care disaggregated by stage 852 1022.4
NCDC_HT_Nw4. 1 Stage I 177 212.4
NCDC_HT_Nw4. 2 Stage II 667 800.4
Severe HTN ( Including HTN emergency
NCDC_HT_Nw4. 3 and urgency) 8 9.6
NCDC_HT_Nw4. 4 Others 0
Total number of cohort hypertensive

patients enrolled to care six month prior to
NCDC_HT_Rx5. the reporting month 260 312
Total number of hypertensive patients

enrolled to care six month prior to the
NCDC_HT_Rx6 reporting month 695 834
NCDC_HT_Rx6. 1 Controlled 373 447.6
NCDC_HT_Rx6. 2 Not controlled 318 381.6
NCDC_HT_Rx6. 3 Lost to follow-up 4 4.8
NCDC_HT_Rx6. 4 Died 0
NCDC_HT_Rx6. 5 Transferred out 0
NCDC_CVD Cardio Vascular Diseases 0
Total number of patients assessed for CVD
NCDC_CVD1 risk 27 32.4
NCDC_CVD1. 1 CVD risk < 10%( Low) 0
NCDC_CVD1. 2 CVD risk 10%-20%(Moderate) 7 8.4
NCDC_CVD1. 3 CVD risk 20%-30%(High) 14 16.8
NCDC_CVD1. 4 CVD risk >=30%(Very High) 6 7.2
Number of patients with CVD risk >= 30%

received treatment during the reporting
CVD_RX.1. period 16 19.2
HSQI Quality of health services 0
OPD_OPAPC.1 Number of outpatient visits 37543 45051.6
OPD_OPAPC.1. 1 < 5 years, Male 2161 2593.2
OPD_OPAPC.1. 2 < 5 years, Female 1841 2209.2
OPD_OPAPC.1. 3 5 - 10 years, Male 1850 2220
OPD_OPAPC.1. 4 5 - 10 years, Female 1947 2336.4
OPD_OPAPC.1. 5 11 - 19 years, Male 1957 2348.4
OPD_OPAPC.1. 10 30 - 45 years, Female 4635 5562
OPD_OPAPC.1. 12 46 - 65 years, Female 3510 4212
OPD_OPAPC.1. 13 >= 66 years, Male 1479 1774.8
OPD_OPAPC.1. 14 >= 66 years, Female 1517 1820.4
Number of CBHI members visit made to HF
FRM_HI_OPAPC.1. in a month 7405 8886
HSQI_IPD_AR Admission rate 0
IPD_AR.1. Number of inpatient admissions 80 96
Bed occupancy rate 76.8 92.16
Length of stay (in days) in the reporting
IPD_BOR.1. period 73 87.6
IPD_BOR.2. Total number of beds 41 49.2
HSQI_IPD_ALOS Average length of stay 0
IPD_ALS.1. Number of inpatient discharges 73 87.6
Total length of stay (in days) during
IPD_LoS.1. discharge 36 43.2
HSQI_IPD_IMR Inpatient mortality rate 0
Number of inpatient deaths in the
IPD_IMR.1. reporting period 0
Proportion of blood units utilized from
HSQI_BDB_UBDU blood bank service 0
Total units of blood received from NBTS &
BDB_UBDR.1. regional blood banks 0
TtBD_UBDT.1 Total number of units of blood transfused 0

TtBD_UBDT.1. 1 direct family replacement 0
TtBD_UBDT.1. 2 from blood bank 0
Serious Adverse Transfusion Incidents and
TtBD_UBDT_SATIR Reactions 0
Number of serious adverse transfusion

UBDT_SATIR.1. incidents and reactions occurred 0
HSQI_ERU_MR Emergency unit/department mortality rate 0 0

ERU_MR.1 Total death in the emergency unit 0
ERU_MR.1. 1 < 15 years, Male 0
ERU_MR.1. 2 < 15 years, Female 0
ERU_MR.1. 3 >= 15 years, Male 0
ERU_MR.1. 4 >= 15 years, Female 0
Total number of emergency unit
ERU_ERA.1. attendances 251 301.2
Number of people referred to other health
RF_RFR.1 facility 1157 1388.4
RF_RFR.1. 1 Emergency referral 357 428.4
RF_RFR.1. 2 Non-emergency referral 800 960
Number of road traffic injury cases dis
RTA_RTI.1 aggregated by accident type 0
RTA_RTI.1. 1 Vehicle occupant 0
RTA_RTI.1. 2 Motor cyclist 0
RTA_RTI.1. 3 Pedestrian 0
RTA_RTI.1. 4 Others 0
HCSM_EDA_TDR Tracer drug availability 0
EDA_TDR.1. Availability of Amoxicillin 4 4.8
EDA_TDR.2. Availability of Oral Rehydration Salt 10 12
EDA_TDR.3. Availability of Zinc 0
EDA_TDR.4. Availability of Gentamycine 8 9.6
EDA_TDR.5. Availability of Cotrimoxazole 240 mg/ 5ml 10 12

Availability of Magnesium Sulphate
EDA_TDR.6. Injection 10 12
EDA_TDR.7. Availability of Oxytocin Injection 10 12
EDA_TDR.8. Availability of Enalapril 10mg tablets 10 12
Availability of Medroxyprogesterone
EDA_TDR.9. (depo) Injection 10 12
EDA_TDR.10. Availability of Glibenclamide 5mg 10 12
Availability of Adrenaline (Epinephrine)
EDA_TDR.11. injection 10 12
Availability of Pentavalent DPT-Hep-Hib
EDA_TDR.12. Vaccine 10 12
EDA_TDR.13. Availability of Glucose 40% 8 9.6
EDA_TDR.14. Availability of Dextrose in normal saline 5 6
EDA_TDR.15. Availability of Ferrous Sailt plus Folic Acid 10 12
EDA_TDR.16. Availability of Ciprofloxacin 500 mg tablet 10 12
EDA_TDR.17. Availability of Ceftriaxone 1 gm injection 10 12

EDA_TDR.18. Availability of Hydralazine injection 9 10.8
EDA_TDR.19. Availability of TDF/3TC/EFV adult 10 12
EDA_TDR.20. Availability of TB (RHZE/RH) patient kit 10 12
EDA_TDR.21. Availability of Tetanus antitoxine (TAT) 9 10.8
EDA_TDR.22. Availability of Tetracycline Eye Ointment 10 12
EDA_TDR.23. Availability of Arthemisin / Lumphantrine 10 12

EDA_TDR.24. Availability of Implanon NXT 10 12
EDA_TDR.25. Availability of Artesuante injection 10 12
Percentage of Clients with 100%
HCSM_Dis_PrDF prescribed drugs filled 891.1 1069.32
Number of clients who received 100% of
Dis_PrDF.1. prescribed drugs 28040 33648
Total number of clients who received
Dis_DPrR.1. prescriptions 31373 37647.6
EBDM Evidence based decision making 0
Proportion of facilities which have done
LQAS 900 1080
Did the HF conduct LQAS for service
DQ_DA1. report? 9 10.8
DQ_DA.1.1. LQAS first score for service report 710 852
DQ_DA.1.2. LQAS last score for service report 750 900
DQ_DA2. Did the HF conduct LQAS for OPD report? 8 9.6

DQ_DA.2.1. LQAS first score for OPD report 725 870
DQ_DA.2.2. LQAS last score for OPD report 750 900
DQ_DA3. Did the HF conduct LQAS for IPD report? 0

DQ_DA.3.1. LQAS first score for IPD report 0
DQ_DA.3.1. LQAS last score for IPD report 0
0.949791 1 0.050209
7.155
4.443
2.712
Note Please select your Region, Zone and Woreda
Region: Addis_Ababa
Zone: Addis_Ababa_No_Zone
Woreda: Arada
EFY 2015 WBHSP
Woreda
Note Please input Woreda's population Template
populati
2014 population
on: 20,934
Baseline
Performance measures Baseline % Eligible # Target # Target % 30,864
Category #
Enhance equitable and quality comprehensive health service
1.1 Maternal, Neonatal, Child and Adolescent Health
1.1.1 Maternal Health
1 Contraceptive Acceptance Rate 2,004 20.12% 6,755 2,162 32%
2 Long acting family planning Rate 533 26.59% 6,755 1,080.86 50%
3 Ratio of Contraceptive Acceptance long term to short Term methods 0.36
4 Immediate postpartum contraceptive acceptance rate (IPPCAR) 10 1.33% 488 59 12%
Proportion of pregnant women who received antenatal care first contact during the
5 583 81.10%
current pregnancy 488 488 100%
6 Proportion of pregnant women who attended ANC4+ during the current pregnancy 341 47.39%
488 302 62%
Proportion of pregnant women who received antenatal care 8 contacts and more
7 during
the current pregnancy 488 98 20%
8 ANC 1 to ANC 4 drop out Rate 242 41.6% 20%
9 Proportion of pregnant women tested for syphilis 583 100.00% 488 488 100%
10 Number of pregnant women who were tested for HBV and who know their results 583 100.00% 488 488 100%
11 Proportion of births attended by skilled health personnel 187 26.03% 488 200 41%
12 Ratio of Skilled Births attendance coverage of Rural to Urban 41%
13 Proportion of women with early PNC within 48 hours after delivery 193 26.87% 488 200 41%
14 Proportion of kebeles declared ‘home delivery free’ 5 100% 5 5 100%
15 Percentage of birth deliver by cesarean section 0 0% 488 - 0%
16 Percentage of women who received uterotonics in the first one min after delivery 415 46 11%
17 Percentage of women who developed PPH after facility or home delivery 488 54 11%
Percentage of pregnant, Laboring and lactating women who were tested for HIV and
18 679 116.46%
who know their results 488 781 100%
Percentage of HIV-positive pregnant women who received ART to reduce the risk
19 of mother-to child-transmission during pregnancy, labor & delivery (L&D) and 13 183.33%
postpartum 10 15 100%
Ratio of HIV+ pregnant women received ARVs for PMTCT (Mothers needing
20
PMTCT) Rural to Urban
21 Proportion of HIV exposed Infants with Virological test 12 90.91% 10 15 100%
Percentage of infants born to HIV-infected women receiving antiretroviral (ARV)
22 7 54.55%
prophylaxis for PMTCT 10 15 100%
Percentage of partners of pregnant, laboring and lactating women tested for HIV
23 116 19.96%
during the reporting month 488 146 30%
24 Proportion of HCs with BEmONC services -
25 Number of women receives comprehensive abortion services 112 155.19% 49 129 100%
26 Still birth rate 2 1.28% 488 1 100%
27 Institutional Maternal mortality rate 0 0.00% 488 0 100%
28 Number of Maternal mortality at community 0 0 0%
Number of Gender based violence/sexual violence (GBV/SV) survivors who
29 12 24
received any service from health facilities 100%
1.1.2 Neonatal and Child Health
Proportion of surviving infants who have received first dose of pentavalent
1 570 308.44%
vaccine 468 633 100%
Proportion of surviving infants who have received three doses of the oral
2 544 294.16%
polio vaccine (OPV3) 468 633 100%
3 IPV (Inactivated Polio Vaccine) Immunization Coverage (< 1 year) 500 270.78% 468 633 100%
4 Proportion of surviving infants vaccinated for Penta-3 544 294.16% 468 633 100%
5 Ratio of surviving infants vaccinated for Penta-3 between Rural and Urban
Proportion of Kebeles with >= 80% of Pentavalent 3 Immunization
6
coverage -
7 Proportion of surviving infants vaccinated for measles (MCV1) 497 7.00% 468 633 100%
Proportion of surviving infants who have received a second dose of measles
8 593 320.78%
(MCV2) vaccine before their second birthday. 468 633 100%
9 Ratio of surviving infants vaccinated for measles between Rural and Urban
10 Drop out Rate Between Penta 1 to Penta 3 26 4.63% 3%
11 Proportion of surviving infants vaccinated for PCV-3 544 294.16% 468 633 100%
12 Proportion of infants fully immunized 532 287.66% 468 633 100%
Proportion of surviving infants who have received two doses of the
13 529 286.36%
Rotavirus vaccine. 468 633 100%
14 Proportion of infants protected at birth against neonatal tetanus 506 274.03% 488 633 100%
15 Measle Vaccine wastage rate 99 8.63% 7%
16 Proportion of girls (14 year old) who has received HPV 1 Immunization 169.2 42.17% 272 144 53%
17 Proportion of girls (14 year old) who has received HPV 2 Immunization 286.8 169.50% 272 330 100%
18 Proportion of Neonata death in the institution 0 0.00% 1 1 100%
19 Proportion of children treated by Zinc and ORS for Diarrhea 187 108.67% 117 215 100%
Proportion of under-five children with pneumonia received antibiotic
20 80 13.48%
treatment 404 113 28%
Proportion of Sick Young infants treated for sepsis/VSD (Very Severe
21 2 0.10%
Disease) 37 4 12%
Proportion of asphyxiated neonates who were resuscitated (with bag & mask)
22 0 #DIV/0!
and survived 49 5 11%
Proportion of low birth weight or premature newborns for whom Kangaroo
23 0 #DIV/0!
Mother Care (KMC) was initiated after delivery 69 8 11%
Proportion of Health posts offering integrated community based case
24
management (iCCM) -
Proportion of Health centers providing Integrated Management of Newborn
25 1 100%
and Childhood Illness (IMNCI) 1 1 100%
Proportion of new borns that received at least one dose of chlohexidine
26 157 0%
dicluchonate (CHX) to the cord on the first day after birth 488 488 100%
1.1.3 Adolescent Health
Proportion of health Centers providing youth friendly service (with minimum
1 1 100%
service package) 1 1 100%
2 Teenage girls (<19 years old) pregnancy rate 61 2% 2,290 23 1%
1.4 Nutrition
Proportion of Children aged 6-59 months who received vitamin A
1 2,435 124.04%
supplementation 1,331 2,922 100%
2 Proportion of Children aged 24 - 59 months de-wormed 1,914 139.67% 930 2,297 100%
3 Proportion of Pregnant received deworming 373 63.99% 488 390 80%
4 Proportion of children under five years screened for acute malnutrition 4,730 107.18%
1,498 5,440 100%
Proportion of children under 2 years of age who participated in Growth
5 1,936 231.25%
Monitoring and Promotion monthly 568 2,226 100%
Proportion of pregnant women received iron and folic acid supplements at
6 647 110.91%
least 90 pluss 488 744 100%
Proportion of pregnant and lactating women (PLW) screened for acute
7 864 148.15%
malnutrition 488 994 100%
Proportion of children 0 - 59 months who treated for complicated sever acute
8 6 26.32%
malnutrion 6 2 40%
Percentage of live births that weigh less than 2,500 gm out of the total live
9 0 0.00%
births weighed 69 8 11%
1.5 Hygiene and Environmental Health
1 Proportion of households having basic sanitation facilities 1 100% 5,106 5,106 100%
2 Proportion of Kebele declared ‘Open Defecation Free’ 2 40% 5 5 100%
3 Proportion of HHs with safe solid waste management 2,701 50% 5,106 3,829 75%
4 Proportion of HHs with safe liquid waste management 2701 50% 5,106 3,829 75%
5 Proportion of health facility with basic sanitation facilities services 1 100% 1 1 100%
6 proportion of health facilities with water supply 1 100% 1 1 100%
7 Proportion of HHs with basic hand washing facilities 1 100% 1 1 100%
8 Proportion of water sources which conducted follow up and inspecttion -
9 Proportion of health facilities with healthcare waste management system 1 100% 1 1 100%
10 Proportion of HHs with separate kichine 1 258
11 Proportion of HHswith smoking free stoves 1 258
1.6 Prevention and Control of Diseases
1.6.1 Major Communicable Diseases
1.6.1.1 HIV/AIDS
1 Proportion of STI cases managed 188 31.79% 285 285 100%
2 Proportion of Sexually Transmitted Infection (STI) cases tested for HIV 176 93.63% 285 285 100%
3 New HIV Case Finding Target 18 40% 67 67 100%
4 Percentage of people living with HIV who know their status 1,814 1,938 1,938 100%
5 Percentage of people living with HIV receiving ART 108 171 162 95%
6 Number of adults and children with HIV infection newly started on ART 37 67 64 95%
7 Proportion of eligible children under 15 years of age receiving ART 0 5 5 95%
Percentage of non-pregnant women living with HIV on ART using a modern family
8 35
planning method 54 46 85%
9 ART Retention rate at 12 months 64 61 95%
Percentage of patients on ART with a suppressed viral load (<1000 copies/ml) in
10 19 44.44%
the past 12 months 171 162 95%
11 Proportion of HIV positive women (15+) on ART screened for Cervical Ca 18 32% 54 27 50% 50% of women in ART are eligibles
12 Number of individuals tested for Hepatitis 0 -
13 Proportion of diagnosed Hepatitis B and C patients who received treatment 0 -
14 Number of OVC/care givers who received startup capital/material for IGA 0 -
15 Number of OVC who received food/nutritional support 0 -
1.6.1.2 TB and Leprosy
1 Proportion of all forms of TB cases notified and treated from community referral 4 44%
29 6 20%
2 Cure rate for bacteriologically confirmed new PTB cases (CR) 55% 90%
3 Treatment Success Rate (TSR) among bacteriologically confirmed PTB cases 88% 96%
4 Number of DR (Drug Resistant) case detected 0 100%
5 Leprosy Case Detection Rate (per 1000 population) 0 0
6 Leprosy treatment completion rate
7 Grade II disability rate among new cases of leprosy
1.6.1.3 TB/HIV
1 Proportion of patients enrolled in HIV care who were screened for TB 108 100% 171 100%
2 TB Screening for HIV positive Clients 107 100% 64 100%
1.6.1.4 Malaria
1 Morbidity attributed to malaria 12 95% 100%
2 Facility based death attributed to malaria 0 100% -
3 Proportion of targeted HHs covered with LLINs in the last 12 months -
Proportion of unit structure covered by Indoor residual spraying (IRS) with in 12
4
months -
1.6.1.5 Other-communicable diseases /Neglected Tropical diseases
Proportion of Trachomatous Trichiasis (TT) cases who received corrective TT
1
surgery -
2 Proportion of individuals who swallowed drug for Trachoma -
3 Number of individuals with confirmed cutanous Leishmaniasis
4 Number of individuals with confirmed visceral Leishmaniasis
5 Proportion of individuals who swallowed drug for lyphatic filariasis -
6 Proportion of Onchocerciasis cases treated in targeted population -
1.6.2 Non-communicable diseases
Proportion of women age 30-49 screened for cervical cancer with visual inspection
1 199 43.10%
with acetic acid (VIA) 240 240 100%
2 Proportion of eligible women who received treatment for cervical lesion 5 22.22% 14 10 70%
3 Proportion of hypertensive adults diagnosed for HPN and know their status 46 2.09% 1,808
904 50%
4 Proportion of hypertensive adults whose blood pressure is controlled 448 53.67% 407
277 68%
Proportion of 1 to 9 years old children treated for Trachoma in endemic woredas
5 with Trachomatous Inflammation Follicular (T.F) -
6 Number of new diabetic patients enrolled to care 32 158.82% 680 48 100%
7 Proportion of DM patients whose blood sugar is controlled 31 6.35% 32 32 100%
8 Cataract Surgical Rate (Per 1,000,000 population) -
1.6.2.1 Mental health
1 Proportion of health centers providing integrated mental health services 152 17% 2,262 679 30%
2 Proportion of eligible population who received care for pychosis 63 25% 105 42 40%
3 Proportion of eligible population who received care for sever Depression 41 27% 1,424 555 39%
4 Proportion of eligible population who received care for Bipola cases 20 20% 126 39 31%
5 Proportion of eligible population who received care for Epilepsy cases 13 4% 209 42 20%
Proportion of eligible population who received care for sever substance use
6 15 36% 398
disorders (Alcohol) 199 50%
1.7 Clinical & Quality of health Services
1 Outpatient attendance per capita 1 1 2 2 100%
2 Ratio of OPD attendance between Rural and Urban
3 Inpatient mortality rate 0 0%
4 Inpatient admission per capita 0.22 1%
5 Average length of stay 204 231
6 Bed occupancy rate 7 85%
Proportion of Health Centers implementing comprehensive Laboratory Quality
7 1 100% 1 1 100%
Management System (LQMS)
8 Proportion of patients with positive experience of care 85% 85% 85 85 100%
9 Percentage of component Production from total collection -
10 Emergecy patient triaged with 5 minutes 100% 100%
1.8 Emergency of health Services
1 Referral out rate 3 1%
2 Facility emergency department mortality rate 0 0%
3 Ambulance Response rate 100% 100%
Improve health emergency and disaster risk management
1 Proportion of epidemics controlled within the standard of mortality
2 Proportion of health facilities reporting complete and timely weekly diseases report
Strengthen governance and leadership
Proportion of Primary health Care facilities implementing Community
1 1 100%
Scorecard (CSC) 1 1 100%
Improve regulatory systems
Proportion of health facilities mplementing compulsory Ethiopian health facility
1 -
standard
2 Proportion of Health Facilities Inspected -
Proportion of food and drinking service establishments that met Ethiopian hygiene
3
and environmental health requirements -
Improve access to pharmaceuticals and medical devices and their rational and prope
1 Proportion of availability of essential drugs at Health Posts
2 Proportion of availability of essential drugs at Health Center 170 69% 80%
3 Percentage of Clients with 100% prescribed drugs filled 33,648 89.38% 92%
4 Pharmaceuticals wastage rate 0 0.14% 1%
5 Functionalities of Medical equipments 83% - 85%
Ensure community participation and engagement
1 Proportion of model households 2,701 73% 5,106 4,289 84%
2 Proportion of functional 1 to 5 networks 370 100% 1,021 1,021 100%
Proportion of health centers and primary hospitals providing major emergency and essential
3 surgical care -
4 Proportion of health posts providing comprehesive health services -
5 Proportion of Primary Health Care Facilities implemented Community Score Card -
6 Proportion of high performing Primary Health Care Units (PHCUs) 85% - 87%
7 Proportion of clients satisfied during their last health care visit (Client satisfaction rate) 85% - 87%
8 Proportion of Model kebeles -
Enhance health financing
Proportion of government health budget allocated to the health sector in the fiscal
1 17,161,496 99%
year 19,469,253 19,469,253 100%
Proportion of eligible households enrolled in Community Based Health Insurance
2 2,331 103%
(CBHI) 1,532 1,532 100%
3 Share of internal revenue generated of total health budget 17,161,496 10% 19,469,253 1,929,198 20%
4 Proportion of reimbursed amount from the total spent - 75%
5 Proportion of eligible civil servants covered by Social Health Insurance (SHI) 0 152 152 100%
6 Per capita health service utilization (for CBHI beneficiaries) 11,437 490% 1,532 1,532 100%
Enhance informed decision making and innovations
1 Proportion of health facilities conducted Lots quality assurance Sampling (LQAS) 100% 100%
Proportion of health facilities meet the data verification factor within 10% range for
2
SBA
3 Proportion of births notified (from total births) 193 100% 488 200 41%
4 Proportion of deaths notified by the health facility 2 100% 1 1 100%
5 Report Timeliness 100% - 100%
6 Report Completeness 100% 100% 100% 1 100%
7 Proportion of development partners/ NGOs aligned their plan with Health Sector -
Enhance digital health technology
Number of new/improved technology (Diagnostics, Therapeutics, Tools, or
1
Vaccines) transferred
Improve human resource development and management
1 Health profesional attrition rate
2 Health workers density per 1,000 population 1;401 1;272
3 Physician to Population ratio (per 1,000 population) 1;15,482 1:10467
4 Health Officer to population ratio (per 1,000 population) 1;2,058 1;1,396
5 Nurse to Population ratio (per 1,000 population) 1;1,235 1;837
6 Midwive to Population ratio (per 1,000 population) 1;3,086 1;2093
7 Emergency service officer to Population ratio (per 1,000 population) 1 1;3,489
8 Level IV health extension to Population ratio 1፡5,141 1;2093
9 Proportion of Health centers staffed with at least two Midwife
10 Proportion health Facility staffed as per the standard 334 45% 334 60%
11 Percentage of health professionals with an active professional license 77 100% 87 100%
12 Laboratory to population ration 1;4,409 1;991
13 Phamacies (all) to Population ration 1;5,144 1;2093
Improve health infrastructure
1 Primary health care coverage 85% 85% 5106 90%
2 Functional Health Posts to population ratio 0
3 Functional Health Centers to population ratio 1;30,864 1;20934
4 Functional Primary Hospitals to population ratio 0
5 Functional General Hospitals to population ratio 0
6 Proportion of health institutions with electricity supply. 2 100% 2 100%
7 Proportion of health institutions with water supply. 2 100% 2 100%
8 Proportion of health facilities with IT network 3 80% 6 100%
9 Proportion of health facilities with Basic health care waste management services 1 100% 1 100%
10 Number of new Health centers constructed 0 0
11 Number of constructed primary hospitals 0
12 Number of Health facility to be maintain 0 1 100%
Improve traditional medicine
1 Number of traditional healers existed in the Woreda
2 Number of advocacy condcuted for traditional healers to link with health system
Enhance health in all policies and strategies
Number of other governmental sectors involving and align their plan with health
1
sector planning, Monitoring & Evaluation
Enhance private engagement in the sector
Number of private organization engaging in the health promotion, diseases
1 prevetion, curative, rehabilitative & palative care in the Woreda
#VALUE!
Region name: Addis_Ababa
Estimates Values for Selected Region
Estimated households size 4.10
Estimated live births 2.3300000000%
Total number of surviving infants at 1 year of age 2.2368000000%
Under 5 year child population 7.1553781834%
<3 yr age group 4.1221978433%
6 – 59 months age group 6.3600000000%
24 – 59 months age group 4.4432098545%
<15 yr age group 23.9654333720%
15-24 age group 28.9052342958%
15-59 age group 70.8872001288%
Women in reproductive age (15 -49 years) 34.6400000000%
Total number of estimated pregnancies / Births 2.3300000000%
Estimated deliveries 2.3300000000%
Non-pregnant women in fertile age 32.2700000000%
Diarrhea Prevalence among <5 years children 7.8000000000%
Diarrhea Episode among <5 years children 1
Pneumonia Prevalence among <5 years children 27.0000000000%
Pneumonia Episode among <5 years children 3
Moderate malnurished 28.3000000000%
Severly malnurished 1.4000000000%
Incidence of Neonatal Asphyxia per live birth 10.0000000000%
Incidence of Neonatal sepsis per live birth 7.6000000000%
Prevalence of malaria in all age Group 7.6000000000%
Leprosy Prevalence 0.7000000000%
TB prevalence per 100000 0.0000010000%
Adult HIV prevalence 0.1400000000%
HIV prevalence among Children <15 years 5.2000000000%
HIV prevalence among pregnant mothers 0.9493008159%
Eligible for ART among adult HIV positives 1.1656729170%
Eligible for ART among Children under 15 years HIV positives 31.1494343387%
Eligible for ART among HIV+ pregnant mothers 31.7799847212%
Eligible among HIV+ pregnant mothers for ART Prophylaxis 1.1656729170%
Proportion OVC among under 15 years children 80.0000000000%
Eligible OVC for educational support 26.4266781747%
Eligible OVC for food support 23.6000000000%
Eligible OVC for shelter support 8.6000000000%
Eligible OVC for IGA support 6.5000000000%
Eligible PLHIV (15-59 years) for food support 4.3000000000%
Eligible PLHIV (15-59 years) for shelter support 25.0000000000%
Eligible PLHIV (15-59 years) for IGA support 15.0000000000%
Cumulative number of PLHIV enrolled in Pre-ART 10.0000000000%
Cumulative number of PLHIV enrolled in ART
Condom distribution 6614400.0000000000%
PMTCT from ANC 22641600.0000000000%
Prevalence of STI 1.9200000000%
Abortion rate 10% of prgeanancy 10.0000000000%
TB +
Women of age 30-49 from total number of Women
Psychosis 19.2000000000%
Bipolar 0.5000000000%
Epilepsy 0.6000000000%
Depression 1.0000000000%
Percentage of Females 9 years old 6.8000000000%
No. Estimates National Addis_Ababa
1 Estimated households size 4.7 4.1
2 Estimated live births 3.362% 2.330%
3 Total number of surviving infants at 1 year of age 3.164% 2.237%
4 Under 5 year child population 14.591% 7.155%
5 <3 yr age group 8.040% 4.122%
6 6 – 59 months age group 13.177% 6.360%
7 24 – 59 months age group 10.720% 4.443%
8 <15 yr age group 44.980% 23.965%
9 15-24 age group 20.581% 28.905%
10 15-59 age group 50.170% 70.887%
11 Women in reproductive age (15 -49 years) 23.400% 34.640%
12 Total number of estimated pregnancies / Births 3.362% 2.330%
13 Estimated deliveries 3.362% 2.330%
14 Non-pregnant women in fertile age 20.038% 32.270%
15 Diarrhea Prevalence among <5 years children 7.800%
16 Diarrhea Episode among <5 years children 1 1
17 Pneumonia Prevalence among <5 years children 27.000% 27.000%
18 Pneumonia Episode among <5 years children 300.000% 300.000%
19 Moderate malnurished 28.700% 28.300%
20 Severly malnurished 8.800% 1.400%
21 Incidence of Neonatal Asphyxia per live birth 10.000% 10.000%
10. -15%
22 Incidence of Neonatal sepsis per live birth 7.600% 7.600%
23 Prevalence of malaria in all age Group 0.700% 0.700%
24 Leprosy Prevalence 0.000% 0.000%
25 TB 0.140% 0.140%
26 Adult HIV prevalence 1.500% 5.200%
27 HIV prevalence among Children <15 years 0.209% 0.949%
28 HIV prevalence among pregnant mothers 1.706% 1.166%
29 Eligible for ART among adult HIV positives 30.116% 31.149%
30 Eligible for ART among Children under 15 years HIV positives 28.135% 31.780%
31 Eligible for ART among HIV+ pregnant mothers 1.706% 1.166%
32 Eligible among HIV+ pregnant mothers for ART Prophylaxis 80.000% 80.000%
33 Proportion OVC among under 15 years children 15.612% 26.427%
34 Eligible OVC for educational support 23.600% 23.600%
35 Eligible OVC for food support 8.600% 8.600%
36 Eligible OVC for shelter support 6.500% 6.500%
37 Eligible OVC for IGA support 4.300% 4.300%
38 Eligible PLHIV (15-59 years) for food support 25.000% 25.000%
39 Eligible PLHIV (15-59 years) for shelter support 15.000% 15.000%
40 Eligible PLHIV (15-59 years) for IGA support 10.000% 10.000%
41 Cumulative number of PLHIV enrolled in Pre-ART
42 Cumulative number of PLHIV enrolled in ART 268934 66144
43 Condom distribution 24713756 226416
44 PMTCT from ANC 2.410% 3.126%
45 Prevalence of STI 1.920% 1.920%
46 Abortion rate 10% of prgeanancy 10.000%
47 TB +
48 Women of age 30-49 from total number of Women 19.200% 19.200%
49 Psychosis 0.500% 0.500%
50 Bipolar 0.600% 0.600%
51 Epilepsy 1.000% 1.000%
52 Depression 6.800% 6.800%
53 Substance use disorderd (Alcohol) 1.900% 1.900%
54 Percentage of Females 9 years old 1.15%
55 Percentage of Females 30 49 years old 11% 12%
Proportion of females of 14 years Age 1.30%
Propertion of teenage female groups 8.16% 10.94%
Low Birth Weight 14.10% 14.10%
Hypertesntion among adults 11.85% 11.85%
Proportion of adult population
Proportion of sever acute malnutrition among <5 year 3.0% 0.4%
Prevalence of diabetices in Ethiopia 6.5% 6.5%
Proportion of adult people (15 - 64 years) 54.9% 72.9%
Prevalences children among < 5 years with SAM 3.0% 0.4%
Proportion of HIV+ non progrnant wemon (out of totla CAR Acceptores 0.30% 0.30%
KCM 10% 10%
admin:
From MCH- Yirdachew
moh:
MCH moh:
recommendati MCH
on based on recommendati
"Global on based on
burden of "Global
childhood burden of
pneumonia childhood
and diarhhea pneumonia
-April 2013 and diarhhea
-April 2013
admin:
EDHS
admin:
Review Article | Open
Access
Volume 2020 |Article ID

7589483 |
https://doi.org/10.1155/
admin:
2020/7589483
EDHS 2016
Show citation
Prevalence and
admin: Determinants of Low
From MCH- Yirdachew Birth Weight in Ethiopia:
A Systematic Review and
Meta-Analysis

2015 Abwarie Target Plan

Uploaded by

Copyright:

Available Formats

You might also like

2015 Abwarie Target Plan

Uploaded by

Document Information

Original Description:

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

2015 Abwarie Target Plan

Uploaded by

Copyright:

Available Formats

Addis Ababa Regional

FP_CAR_Mtd_New Contraceptive new acceptors, by method 1019 1222.8

Total Immediate Postpartum

Total Immediate Postpartum

Total Long acting family planning (LAFP)

Total number of premature removal of

Number of pregnant women who received

Number of pregnant women that received

Total number of pregnant women that

RMH_L&D_SBA Births attended by skilled health personnel 0

NCH_CHIM_EIND Early Institutional Neonatal Death Rate 0

Number of women receiving

RMH_CAC_PAC Number of post abortion/emergency care 12 14.4

Number of women receiving

Number of pregnant women tested and

Number of pregnant women tested and

Number of women tested and know their

Number of women with known HIV

Percentage of HIV-positive pregnant

Number of HIV positive Pregnant women

Number of HIV positive lactating women

Number of HIV-positive women who get

Total number of infants within 12 months

Number of HIV exposed infants who

Number of HIV exposed infants who

Percentage of Infants born to HIV-infected

Number of infants born to HIV positive

Percentage of Infants born to HIV-infected

Percentage of partners of pregnant,

Number of partners of pregnant, laboring

Number of partners of pregnant, laboring

Number of HIV exposed infants receiving

NCH_EPI Expanded Program of Immunization (EPI) 0

Number of children under one year of age

Number of children under one year of age

Number of children under one year of age

Number of children under one year of age

Number of children under one year of age

Number of children under one year of age

Number of children under one year of age

Number of children under one year of age

Number of children under one year of age

Number of children under two years of age

Number of Infants whose mothers had

Number of girls 14 year of age who have

Number of girls 14 years of age who have

VWR_Penta_dis. Pentavalent (DPT-HepB-Hib) doses expired 0

Number of sick young infants 0-2 months

Proportion of low birth weight and/or

Total number of newborns weighing

Asphyxiated neonates who were

CHIM_AsfxR. Total number of neonates resuscitated 0

Number of weights recorded with

Number of weights recorded with severe

Number of children <5 year screened and

Treatment outcome for management of

Number of children who exit from severe

Total number of children aged 6-59